Company: TVRD
Filing Date: 2025-08-14
Form Type: 8-K
Source: 0001104659-25-078665
Chunk: 0

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-08-14
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02. Results of Operations and Financial Condition.

On August 14, 2025, Tvardi
Therapeutics, Inc. (formerly Cara Therapeutics, Inc.) (the “ Company”) issued a press release announcing its financial results
for the fiscal quarter ended June 30, 2025. A copy of the Company’s press release dated August 14, 2025 is attached hereto as Exhibit
99.1 and is incorporated herein by reference.

The information contained
herein and the accompanying Exhibit 99.1 is being furnished under “ Item 2.02 Results of Operations and Financial Condition”
and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be deemed
incorporated by reference in any filing with the Securities and Exchange Commission made by us, whether made before or after the date
hereof, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.